UNSPSC 85711001: Revision of nonautologous tissue substitute in left acromioclavicular joint, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left acromioclavicular joint, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RWHXKZ

UNSPSC 85711001 Revision of nonautologous tissue substitute in left acromioclavicular joint, external approach is a Commodity code with little relevant recent state and local procurement activity. The code's nominal scope describes a specific orthopedic surgical procedure, but the recent opportunities tagged under it do not align with that clinical definition. The six posted solicitations—spanning independent medical evaluation services, surgery benefit carve-out programs, occupational medical surveillance, specialty and emergency medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing—represent health system administration, vendor management, and clinical staffing services rather than tissue-substitute procurement or orthopedic revision surgery. This mismatch suggests either tagging error at the issuing-jurisdiction level or a data classification issue; the code does not appear to capture actual procurement of orthopedic implants or revision-procedure supplies for state and local health systems.

The issuing bodies in the recent block span county health systems (Santa Clara County Health System, Harris County Juvenile Probation Department), municipal government (City of Phoenix Retirement Office for pension boards, City of Long Beach), county government (Collier County Board of County Commissioners), and state transportation (Washington State Department of Transportation on behalf of Washington State Ferries). Geographic activity appears across Arizona, California, Florida, Texas, and Washington, but reflects health-system and government-employee benefits administration rather than procurement aligned with the code's stated scope. Without evidence of actual orthopedic implant or surgical-supply procurement under this code, the category merits close attention during RFP review to confirm whether a given opportunity is genuinely seeking tissue-substitute products or has been miscoded by the issuing authority.